1. The role of fructose 1,6-bisphosphate-mediated glycolysis/gluconeogenesis genes in cancer prognosis
   Chien-Hsiu Li et al, 2022, Aging CrossRef
2. A prognostic 4-gene expression signature for patients with HER2-negative breast cancer receiving taxane and anthracycline-based chemotherapy
   Pu Cheng et al, 2017, Oncotarget CrossRef
3. Targeting FBPase is an emerging novel approach for cancer therapy
   Gao-Min Liu et al, 2018, Cancer Cell International CrossRef
4. UCP1 regulates ALDH-positive breast cancer stem cells through releasing the suppression of Snail on FBP1
   Fuchuang Zhang et al, 2021, Cell Biology and Toxicology CrossRef
5. Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancer
   Md Sumon Sarkar et al, 2023, Heliyon CrossRef
6. Unraveling the Effect of Breast Cancer Patients’ Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles
   Mahdieh Nemati et al, 2021, Molecular Pharmaceutics CrossRef
7. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients
   Z. Zhao et al, 2020, Clinical and Translational Oncology CrossRef
8. Breast Cancer Molecular Subtypes Differentially Express Gluconeogenic Rate-Limiting Enzymes—Obesity as a Crucial Player
   Carla Luís et al, 2023, Cancers CrossRef
9. SWI/SNF chromatin remodeling complex and glucose metabolism are deregulated in advanced bladder cancer
   Malgorzata Stachowiak et al, 2020, IUBMB Life CrossRef
10. The relationship between hypoxia-inducible factor 1α (HIF-1α) and patient survival in breast cancer: Systematic review and meta-analysis
    Suad A.K. Shamis et al, 2021, Critical Reviews in Oncology/Hematology CrossRef